reference/1087485

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1087485

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	168
issn	1556-0864
issueIdentifier	1
pageRange	161-168
publicationName	Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
startingPage	161
bibliographicCitation	Vergnenegre A, Corre R, Berard H, Paillotin D, Dujon C, Robinet G, Crequit J, Bota S, Thomas P, Chouaid C; 0506 GFPC Team. Cost-effectiveness of second-line chemotherapy for non-small cell lung cancer: an economic, randomized, prospective, multicenter phase III trial comparing docetaxel and pemetrexed: the GFPC 05-06 study. J Thorac Oncol. 2011 Jan;6(1):161–8. doi: 10.1097/jto.0b013e318200f4c1. PMID: 21150465.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0811eeb9668acfd1993986220818356e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c6c8ed79ee173ad09d191177ed922414 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b760e08b60415ab1310072438e0f7bb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3633260578d037752e520b052a267c47 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_287511ebb13fc96ab501b275d9589bcc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4813967c25f8ac588151f24f4fde11cd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e415b12b76121991d3ed5f9d65875fd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_289c0f84ff8ecad42db6ea6fc43a64c9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b6da383d554aebe1d8b73a0a5af7abc7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cea22e9be3db3f6dc9da7a62ece249e4
date	201101
identifier	https://doi.org/10.1097/jto.0b013e318200f4c1 https://pubmed.ncbi.nlm.nih.gov/21150465
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33311 https://portal.issn.org/resource/ISSN/1556-0864
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Cost-Effectiveness of Second-Line Chemotherapy for Non-small Cell Lung Cancer: An Economic, Randomized, Prospective, Multicenter Phase III Trial Comparing Docetaxel and Pemetrexed: The GFPC 05-06 Study
discusses	http://id.nlm.nih.gov/mesh/M0017026 http://id.nlm.nih.gov/mesh/M0009376 http://id.nlm.nih.gov/mesh/M0443608 http://id.nlm.nih.gov/mesh/M0227083 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0009679 http://id.nlm.nih.gov/mesh/M0184558
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D005971Q000191 http://id.nlm.nih.gov/mesh/D000970Q000191 http://id.nlm.nih.gov/mesh/D043823Q000191 http://id.nlm.nih.gov/mesh/D008175Q000191 http://id.nlm.nih.gov/mesh/D002289Q000191 http://id.nlm.nih.gov/mesh/D016879 http://id.nlm.nih.gov/mesh/D006147Q000031
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D010984Q000009 http://id.nlm.nih.gov/mesh/D002289Q000473 http://id.nlm.nih.gov/mesh/D008175Q000473 http://id.nlm.nih.gov/mesh/D002294Q000191 http://id.nlm.nih.gov/mesh/D002289Q000188 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D002294Q000473 http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D006147Q000627 http://id.nlm.nih.gov/mesh/D005971Q000627 http://id.nlm.nih.gov/mesh/D000068437 http://id.nlm.nih.gov/mesh/D008175Q000188 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D043823Q000627 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000077143 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D006147Q000191 http://id.nlm.nih.gov/mesh/D002294Q000188
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410875 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129439837 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159660

Total number of triples: 72.